The RIQAS Immunosuppressant EQA programme has been designed to cover the analysis of Immunosuppressants in clinical laboratories. Immunosuppressants are primarily used after transplant operations to prevent the host body from rejecting donor organs.
Lyophilised samples for enhanced stability

Submit results and view reports online via RIQAS.Net
LC/MS reference values provided for result comparison to an assigned value
Monthly reporting for earlier identification of test system errors
Cycle Starts - March 2026
Accredited to ISO17043:2023 standard via RIQAS flexible scope
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| Immunosuppressant | Monthly | 12 x 2 ml | RQ9159 |
Therapeutic Drugs
Immunoassay
Immunoassay Speciality 2